Benitec Biopharma Announces Late Breaking Oral Abstract Presentation on BB-301 Phase 1b/2a Clinical Study at the 29th Annual Congress of the World Muscle Society
Celldex Announces Upcoming Late Breaking Oral Presentation of 52 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EADV Congress 2024
KraneShares to Host Fireside Chat with Foreign Policy Expert and Kamala Harris-Advisor Peter Harrell and U.S. Ambassador to Singapore (Ret.) David Adelman at Future Proof Festival